ExploreWatchlistsPricing
  1. JP-listed companies
  2. OncoTherapy Science, Inc.
  3. Financials
  4. Stockholders' equity

OncoTherapy Science, Inc. (4564)

Market cap
¥6.4B
P/E ratio
OncoTherapy Science develops cancer treatments using genetic research, including targeted drugs, immunotherapies, and precision medicine testing for personalized cancer care.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025729+106.16%
Mar 31, 2024354-58.64%
Mar 31, 2023855-56.81%
Mar 31, 20221,980-35.64%
Mar 31, 20213,077-34.93%
Mar 31, 20204,728-2.91%
Mar 31, 20194,870-35.75%
Mar 31, 20187,580-24.98%
Mar 31, 201710,104-22.95%
Mar 31, 201613,115-18.36%
Mar 31, 201516,064-9.67%
Mar 31, 201417,783

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat